BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roca A, Afolabi MO, Saidu Y, Kampmann B. Ebola: a holistic approach is required to achieve effective management and control. J Allergy Clin Immunol 2015;135:856-67. [PMID: 25843598 DOI: 10.1016/j.jaci.2015.02.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Madhav N, Oppenheim B, Gallivan M, Mulembakani P, Rubin E, Wolfe N. Pandemics: Risks, Impacts, and Mitigation. In: Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R, editors. Disease Control Priorities, Third Edition (Volume 9): Improving Health and Reducing Poverty. The World Bank; 2017. pp. 315-45. [DOI: 10.1596/978-1-4648-0527-1_ch17] [Cited by in Crossref: 116] [Cited by in F6Publishing: 16] [Article Influence: 29.0] [Reference Citation Analysis]
2 Coarsey CT, Esiobu N, Narayanan R, Pavlovic M, Shafiee H, Asghar W. Strategies in Ebola virus disease (EVD) diagnostics at the point of care. Crit Rev Microbiol 2017;43:779-98. [PMID: 28440096 DOI: 10.1080/1040841X.2017.1313814] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
3 Penrith ML, Bastos A, Chenais E. With or without a Vaccine-A Review of Complementary and Alternative Approaches to Managing African Swine Fever in Resource-Constrained Smallholder Settings. Vaccines (Basel) 2021;9:116. [PMID: 33540948 DOI: 10.3390/vaccines9020116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bedrosian SR, Young CE, Smith LA, Cox JD, Manning C, Pechta L, Telfer JL, Gaines-McCollom M, Harben K, Holmes W, Lubell KM, McQuiston JH, Nordlund K, O'Connor J, Reynolds BS, Schindelar JA, Shelley G, Daniel KL. Lessons of Risk Communication and Health Promotion - West Africa and United States. MMWR Suppl 2016;65:68-74. [PMID: 27386834 DOI: 10.15585/mmwr.su6503a10] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
5 Aruna A, Mbala P, Minikulu L, Mukadi D, Bulemfu D, Edidi F, Bulabula J, Tshapenda G, Nsio J, Kitenge R, Mbuyi G, Mwanzembe C, Kombe J, Lubula L, Shako JC, Mossoko M, Mulangu F, Mutombo A, Sana E, Tutu Y, Kabange L, Makengo J, Tshibinkufua F, Ahuka-Mundeke S, Muyembe JJ, Cdc ER; CDC Ebola Response. Ebola Virus Disease Outbreak - Democratic Republic of the Congo, August 2018-November 2019. MMWR Morb Mortal Wkly Rep 2019;68:1162-5. [PMID: 31856146 DOI: 10.15585/mmwr.mm6850a3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
6 Kost GJ. Molecular and point-of-care diagnostics for Ebola and new threats: National POCT policy and guidelines will stop epidemics. Expert Review of Molecular Diagnostics 2018;18:657-73. [DOI: 10.1080/14737159.2018.1491793] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
7 Gehre F, Otu J, Kendall L, Forson A, Kwara A, Kudzawu S, Kehinde AO, Adebiyi O, Salako K, Baldeh I, Jallow A, Jallow M, Dagnra A, Dissé K, Kadanga EA, Idigbe EO, Onubogu C, Onyejepu N, Gaye-Diallo A, Ba-Diallo A, Rabna P, Mane M, Sanogo M, Diarra B, Dezemon Z, Sanou A, Senghore M, Kwambana-Adams BA, Demba E, Faal-Jawara T, Kumar S, Tientcheu LD, Jallow A, Ceesay S, Adetifa I, Jaye A, Pallen MJ, D'Alessandro U, Kampmann B, Adegbola RA, Mboup S, Corrah T, de Jong BC, Antonio M. The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance. BMC Med 2016;14:160. [PMID: 27806714 DOI: 10.1186/s12916-016-0704-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
8 Ellebedy AH, Ahmed R. Antiviral Vaccines: Challenges and Advances. The Vaccine Book. Elsevier; 2016. pp. 283-310. [DOI: 10.1016/b978-0-12-802174-3.00015-1] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
9 Bonney JHK, Hayashi T, Dadzie S, Agbosu E, Pratt D, Nyarko S, Asiedu-Bekoe F, Ido E, Sarkodie B, Ohta N, Yamaoka S. Molecular detection of dengue virus in patients suspected of Ebola virus disease in Ghana. PLoS One 2018;13:e0208907. [PMID: 30566466 DOI: 10.1371/journal.pone.0208907] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
10 Oluwagbemi O, Oluwagbemi F, Abimbola O. Ebinformatics: Ebola fuzzy informatics systems on the diagnosis, prediction and recommendation of appropriate treatments for Ebola virus disease (EVD). Informatics in Medicine Unlocked 2016;2:12-37. [DOI: 10.1016/j.imu.2015.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 Venkatesan A, Ravichandran L, Dass JFP. Computational Drug Design against Ebola Virus Targeting Viral Matrix Protein VP30. Borneo J Pharm 2019;2:71-81. [DOI: 10.33084/bjop.v2i2.836] [Reference Citation Analysis]
12 Margherita A, Elia G, Klein M. Managing the COVID-19 emergency: A coordination framework to enhance response practices and actions. Technol Forecast Soc Change 2021;166:120656. [PMID: 33551496 DOI: 10.1016/j.techfore.2021.120656] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Zhang X, Rong Y, Sun L, Liu L, Su H, Zhang J, Teng G, Du N, Chen H, Fang Y, Zhan W, Kanu AB, Koroma SM, Jin B, Xu Z, Song H. Prognostic Analysis of Patients with Ebola Virus Disease. PLoS Negl Trop Dis 2015;9:e0004113. [PMID: 26398207 DOI: 10.1371/journal.pntd.0004113] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
14 Adigwe OP, Mohammed EN, Onavbavba G. International training of pharmacists and fitness to practice in Nigeria: Emergent issues and novel insights. Currents in Pharmacy Teaching and Learning 2022. [DOI: 10.1016/j.cptl.2022.04.006] [Reference Citation Analysis]
15 Rugarabamu S, George J, Mbanzulu KM, Mwanyika GO, Misinzo G, Mboera LEG. Estimating Risk of Introduction of Ebola Virus Disease from the Democratic Republic of Congo to Tanzania: A Qualitative Assessment. Epidemiologia 2022;3:68-80. [DOI: 10.3390/epidemiologia3010007] [Reference Citation Analysis]
16 Kieh MD, Cho EM, Myles IA. Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak. PLoS One 2017;12:e0179356. [PMID: 28640889 DOI: 10.1371/journal.pone.0179356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
17 Patel S, Patel S. Analysis of Ebola virus polymerase domains to find strain-specific differences and to gain insight on their pathogenicity. Virusdisease 2016;27:242-50. [PMID: 28466035 DOI: 10.1007/s13337-016-0334-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
18 Vaz RG, Mkanda P, Banda R, Komkech W, Ekundare-Famiyesin OO, Onyibe R, Abidoye S, Nsubuga P, Maleghemi S, Hannah-Murele B, Tegegne SG. The Role of the Polio Program Infrastructure in Response to Ebola Virus Disease Outbreak in Nigeria 2014. J Infect Dis 2016;213 Suppl 3:S140-6. [PMID: 26908718 DOI: 10.1093/infdis/jiv581] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
19 Suwalowska H, Amara F, Roberts N, Kingori P. Ethical and sociocultural challenges in managing dead bodies during epidemics and natural disasters. BMJ Glob Health 2021;6:e006345. [PMID: 34740913 DOI: 10.1136/bmjgh-2021-006345] [Reference Citation Analysis]
20 Fedson DS, Rordam OM. Treating Ebola patients: a 'bottom up' approach using generic statins and angiotensin receptor blockers. Int J Infect Dis 2015;36:80-4. [PMID: 26143190 DOI: 10.1016/j.ijid.2015.04.019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
21 Ashworth HC, Dada S, Buggy C, Lees S. The Importance of Developing Rigorous Social Science Methods for Community Engagement and Behavior Change During Outbreak Response. Disaster Med Public Health Prep 2020;:1-6. [PMID: 32641188 DOI: 10.1017/dmp.2020.163] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Vandebosch A, Mogg R, Goeyvaerts N, Truyers C, Greenwood B, Watson-Jones D, Herrera-Taracena G, Parys W, Vangeneugden T. Simulation-guided phase 3 trial design to evaluate vaccine effectiveness to prevent Ebola virus disease infection: Statistical considerations, design rationale, and challenges. Clin Trials 2016;13:57-65. [PMID: 26768568 DOI: 10.1177/1740774515621059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
23 Chenais E, Wennström P, Kartskhia N, Fischer K, Risatti G, Chaligava T, Enukidze T, Ståhl K, Vepkhvadze NG. Perceptions of pastoralist problems: A participatory study on animal management, disease spectrum and animal health priorities of small ruminant pastoralists in Georgia. Prev Vet Med 2021;193:105412. [PMID: 34144495 DOI: 10.1016/j.prevetmed.2021.105412] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Shoman H, Karafillakis E, Rawaf S. The link between the West African Ebola outbreak and health systems in Guinea, Liberia and Sierra Leone: a systematic review. Global Health 2017;13:1. [PMID: 28049495 DOI: 10.1186/s12992-016-0224-2] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 13.4] [Reference Citation Analysis]